(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists

Details for Australian Patent Application No. 2004299456 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Colandrea, Vincent J.; Hale, Jeffrey J.; Legiec, Irene E.; Vachal, Petr; Yan, Lin; Toth, Leslie; Doherty, George A.; Huo, Pei

Agent Spruson & Ferguson

Pub. Number AU-B-2004299456

PCT Pub. Number WO2005/058848

Priority 60/530,186 17.12.03 US

Filing date 13 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 7 October 2010

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/443 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 285/12 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/058848 Priority application(s): WO2005/058848

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 October 2010 Application Accepted

  Published as AU-B-2004299456

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299457-A human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

2004299455-Cyclopropane compounds and pharmaceutical use thereof